These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18544961)

  • 1. Comparative genomic hybridisation arrays: high-throughput tools to determine targeted therapy in breast cancer.
    Tan DS; Reis-Filho JS
    Pathobiology; 2008; 75(2):63-74. PubMed ID: 18544961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated profiling of basal and luminal breast cancers.
    Adélaïde J; Finetti P; Bekhouche I; Repellini L; Geneix J; Sircoulomb F; Charafe-Jauffret E; Cervera N; Desplans J; Parzy D; Schoenmakers E; Viens P; Jacquemier J; Birnbaum D; Bertucci F; Chaffanet M
    Cancer Res; 2007 Dec; 67(24):11565-75. PubMed ID: 18089785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
    Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
    Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic signatures in breast cancer.
    Fu J; Jeffrey SS
    Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of genomic tools for the molecular understanding of breast cancer and to guide personalized medicine.
    Foekens JA; Wang Y; Martens JW; Berns EM; Klijn JG
    Drug Discov Today; 2008 Jun; 13(11-12):481-7. PubMed ID: 18549973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis.
    Liu BH; Goh CH; Ooi LL; Hui KM
    Oncogene; 2008 Jul; 27(29):4128-36. PubMed ID: 18332864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genomic profile of HER2-amplified breast cancers: the influence of ER status.
    Marchiò C; Natrajan R; Shiu KK; Lambros MB; Rodriguez-Pinilla SM; Tan DS; Lord CJ; Hungermann D; Fenwick K; Tamber N; Mackay A; Palacios J; Sapino A; Buerger H; Ashworth A; Reis-Filho JS
    J Pathol; 2008 Dec; 216(4):399-407. PubMed ID: 18810758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of targeted and whole genome analysis of postnatal specimens using a commercially available array based comparative genomic hybridisation (aCGH) microarray platform.
    Aston E; Whitby H; Maxwell T; Glaus N; Cowley B; Lowry D; Zhu XL; Issa B; South ST; Brothman AR
    J Med Genet; 2008 May; 45(5):268-74. PubMed ID: 18178633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome.
    Monni O; Hyman E; Mousses S; Barlund M; Kallioniemi A; Kallioniemi OP
    Semin Cancer Biol; 2001 Oct; 11(5):395-401. PubMed ID: 11562182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Array-CGH and breast cancer.
    van Beers EH; Nederlof PM
    Breast Cancer Res; 2006; 8(3):210. PubMed ID: 16817944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoom-in array comparative genomic hybridization (aCGH) to detect germline rearrangements in cancer susceptibility genes.
    Staaf J; Borg A
    Methods Mol Biol; 2010; 653():221-35. PubMed ID: 20721746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGH microarrays and cancer.
    Kallioniemi A
    Curr Opin Biotechnol; 2008 Feb; 19(1):36-40. PubMed ID: 18162393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microrevolution: applications and impacts of microarray technology on molecular biology and medicine (review).
    Goldsmith ZG; Dhanasekaran N
    Int J Mol Med; 2004 Apr; 13(4):483-95. PubMed ID: 15010847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy.
    Popescu NC; Zimonjic DB
    Am J Med Genet; 2002 Oct; 115(3):142-9. PubMed ID: 12407694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of breast cancer by array comparative genomic hybridization.
    Climent J; Garcia JL; Mao JH; Arsuaga J; Perez-Losada J
    Biochem Cell Biol; 2007 Aug; 85(4):497-508. PubMed ID: 17713584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighted clustering of called array CGH data.
    Van Wieringen WN; Van De Wiel MA; Ylstra B
    Biostatistics; 2008 Jul; 9(3):484-500. PubMed ID: 18156651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of probe coverage for high-resolution oligonucleotide aCGH.
    Lipson D; Yakhini Z; Aumann Y
    Bioinformatics; 2007 Jan; 23(2):e77-83. PubMed ID: 17237109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data.
    Klijn C; Holstege H; de Ridder J; Liu X; Reinders M; Jonkers J; Wessels L
    Nucleic Acids Res; 2008 Feb; 36(2):e13. PubMed ID: 18187509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full complexity genomic hybridization on 60-mer oligonucleotide microarrays for array comparative genomic hybridization (aCGH).
    Protopopov A; Feng B; Chin L
    Methods Mol Biol; 2008; 439():87-100. PubMed ID: 18370097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.